An interventional study of multidisciplinary precision care in Nurse's Role, Multidisciplinary Communication and Chronic Heart Failure, sponsored by Zhongshan People's Hospital, Guangdong, China. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Zhongshan People's Hospital, Guangdong, China · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Communication with a site in China — 4 open to participants now, 4 under way, none of them phase 3. Communication · China.
Among the 13 studies in Communication with a site in China, this one is the 10th largest by enrollment of the 12 interventional ones that give a count, is the only one that started in 2021, is one of 12 with no phase, and was the 5th registered.
720 studies on the registry are indexed under Communication; 160 are open to participants now.
Browse Communication studies →4 of the 13 studies in Communication with a site in China are open now. Recruiting first, the newest first:
Bao Yan · Sites in China
Healthy volunteers
The Hong Kong Polytechnic University · Sites in China
Ages 18+ · Healthy volunteers
Beijing Normal University · Sites in China
Ages 18–30
Fudan University · Sites in China
Ages 18+ · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 88 Communication studies recruiting now, 53 (60%) set no upper age limit and 28 (32%) stop at 75 or younger; 32 take children under 18; 34 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 1 started in 2021.
This study's enrollment of 96 is below the median of 144 across 572 interventional studies indexed under Communication.
Median enrollment 172 across the 12 interventional studies, 66 across the 1 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 10 most frequent:
Zhongshan People's Hospital, Guangdong, China is the lead sponsor of 11 studies on the registry; 8 are open to participants now.
Zhongshan People's Hospital, Guangdong, China has 1 study filed under Communication — fewer than ten, so there is no comparison to draw.
1 of the studies in Communication with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07803380Beijing Normal UniversityCognitive and Emotional Inoculation Against Nutrition-Related Misinformation in Young Adults | 2026-12-30 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Communication with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aimed to evaluate the feasibility and effectiveness of a nurse-led multidisciplinary precision care in early cardiac rehabilitation of patients with chronic heart failure, and further to promote the application of nurse-led multidisciplinary precision care.
Patients with acute onset CHF who received average 10 days hospitalization of nurse-led multidisciplinary precision care or standard care from Nov. 2021 to Aug. 2022 were retrospectively enrolled as a 1:1 ratio into the multidisciplinary precision care group and the control group. The nurse-led multidisciplinary team assisted participants in early cardiac rehabilitation, including mental and physical recovery. Cardiac function indexes included left ventricular ejection fraction and six-minute walking distance. Changes in cardiac function and short-term outcomes, including adherence to cardiac rehabilitation, length of stay, quality of life, symptom checklist-90 score, performance status score, complications such as cardiac adverse events, and re-hospitalization, were compared between groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Aged from 18 to 80 years; Conscious, with normal cognitive function and being communicable; heart function class II-IV; Patients met the diagnostic criteria of the clinical guidelines for the diagnosis and treatment of heart failure and were diagnosed with chronic heart failure; was obtained.
Exclusion Criteria:
Patients with congenital heart disease, cardiac shock, or persistent hypotension; Patients with severe liver and kidney dysfunction, moderate to severe anemia or coagulation disorders, and other serious systemic complications; Patients with a history of mental illness, a state of severe anxiety or depression, cognitive or communication impairments, and inability to communicate and respond to investigations; Patients have been involved in other research that would interfere with this study; Patients who declined cardiac rehabilitation and signed .
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Give the intervention of nurse-led multidisciplinary precision care
Other: multidisciplinary precision care
standard care according to guidelines
The experimental group received precision nursing based on a multidisciplinary collaborative team in addition to standard treatment and care
left ventricular ejection fraction
Time frame: baseline, pre-intervention, 1 month after intervention, 3 months after intervention
6-minute walking distance
Time frame: baseline, pre-intervention, 1 month after intervention, 3 months after intervention
the European Organization for Research and Treatment of Cancer (EORTC) quality-of-life (QoL) questionnaires (QLQ) QLQ-C30 (version 3.0) score Quality of Life
Time frame: baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Symptom Check List-90
Time frame: baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Performance Status Score
Time frame: baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Numbers of patients with cardiovascular complications
Time frame: baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2021 to primary completion in Nov 2022, 13 months.
Of 389 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 13 months is below that.
Counting every sponsor, half of 393 studies reached it within 18 months; a quarter within 6 and three quarters within 36.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start Nov 2021 → Oct 2021, primary completion Apr 2023 → Nov 2022 and completion Dec 2024 → Apr 2023.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zhongshan People's Hospital, Guangdong, China